
Gland Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Gland Pharma Receives Tentative Approval for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC)".
Filed with NSE · · 2 pages · English

Gland Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Gland Pharma Receives Tentative Approval for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC)".
Follow Gland Pharma into a list and get an email when it puts out news.
Follow Gland Pharma